Deciphering cellular and viral determinants of lytic HSV-1 infection, latency and reactivation
The DecipherHSV project aims to uncover the molecular mechanisms of HSV-1 infection and latency using advanced computational tools and single-cell RNA sequencing to inform new therapeutic strategies.
Projectdetails
Introduction
Herpes simplex virus 1 (HSV-1) is an important human pathogen that infects the majority of the world's population and inflicts a substantial burden of disease. Over the past 10 years, systems biology approaches, to which my lab has provided seminal contributions, have substantially broadened our understanding of the complex interaction of this common pathogen with its human host.
Knowledge Gaps
However, the underlying molecular mechanisms remain poorly understood, and their importance for virus latency and reactivation remains elusive. Furthermore, currently available technology lacks the temporospatial resolution to decipher the cellular and viral determinants that govern the virus life cycle.
Project Goals
The main goal of DecipherHSV is to close these knowledge and technology gaps and decipher novel mechanisms and their functional interplay by which HSV-1 manipulates its host cells throughout the virus life cycle.
Objectives
Accordingly, the three primary objectives of DecipherHSV are to:
- Decipher the full complement of viral elements that govern productive infection.
- Decipher how and why HSV-1 manipulates pervasive transcription within the host and viral genome.
- Decipher the cellular and viral determinants of HSV-1 latency and reactivation.
Methodology
Alongside, I will develop new computational approaches and integrative analysis tools, and employ artificial intelligence to exploit the wealth of information that is provided by the novel single-cell RNA sequencing approaches, which I will pioneer (Heterogeneity-seq and Perturb-scSLAM-seq).
Expected Outcomes
Thereby, I will deliver new leads for novel therapeutic approaches targeting HSV-1 latency and reactivation. This will provide a paradigm for the study of other herpesviruses and their complex host-pathogen interactions.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 1.998.008 |
Totale projectbegroting | € 1.998.008 |
Tijdlijn
Startdatum | 1-5-2022 |
Einddatum | 30-4-2028 |
Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- MEDIZINISCHE HOCHSCHULE HANNOVERpenvoerder
- JULIUS-MAXIMILIANS-UNIVERSITAT WURZBURG
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Interplay of CMV with cellular pathways, states and cell typesThis project aims to develop advanced tools to investigate HCMV-host interactions, uncover viral protein functions, and identify infection vulnerabilities to enhance therapeutic strategies. | ERC Consolid... | € 2.000.000 | 2025 | Details |
Mechanisms of Kaposi's sarcoma herpesvirus replication and maintenance during latencyThis project aims to develop an innovative Xenopus egg extract system to study KSHV latency mechanisms, paving the way for targeted therapies against KSHV-related cancers. | ERC Starting... | € 1.494.774 | 2024 | Details |
Dynamics and heterogeneity of early viral infectionThis project aims to enhance imaging technology to study early infection processes of negative-sense RNA viruses, focusing on RSV to understand viral propagation and inform therapeutic strategies. | ERC Consolid... | € 2.000.000 | 2023 | Details |
Endogenous Human Herpesvirus: Germ line integration and effects on host cell and organismThe ENDo-HERPES project aims to investigate the functional impact of integrated HHV-6 on disease development, telomere dynamics, and host cell interactions using advanced technologies. | ERC Consolid... | € 2.000.000 | 2023 | Details |
Interrogating RNA-protein interactions underlying SARS-CoV-2 infection and antiviral defenseThis project aims to decode RNA-protein interactions in SARS-CoV-2 to understand its replication cycle and identify potential antiviral targets for treating viral diseases. | ERC Starting... | € 1.500.000 | 2022 | Details |
Interplay of CMV with cellular pathways, states and cell types
This project aims to develop advanced tools to investigate HCMV-host interactions, uncover viral protein functions, and identify infection vulnerabilities to enhance therapeutic strategies.
Mechanisms of Kaposi's sarcoma herpesvirus replication and maintenance during latency
This project aims to develop an innovative Xenopus egg extract system to study KSHV latency mechanisms, paving the way for targeted therapies against KSHV-related cancers.
Dynamics and heterogeneity of early viral infection
This project aims to enhance imaging technology to study early infection processes of negative-sense RNA viruses, focusing on RSV to understand viral propagation and inform therapeutic strategies.
Endogenous Human Herpesvirus: Germ line integration and effects on host cell and organism
The ENDo-HERPES project aims to investigate the functional impact of integrated HHV-6 on disease development, telomere dynamics, and host cell interactions using advanced technologies.
Interrogating RNA-protein interactions underlying SARS-CoV-2 infection and antiviral defense
This project aims to decode RNA-protein interactions in SARS-CoV-2 to understand its replication cycle and identify potential antiviral targets for treating viral diseases.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Hacking the ribosome to map virus-host associationsThe VirHoX project aims to map virus-host associations using a novel technique, VirHo-seq, to enhance understanding of viral interactions and address challenges posed by emerging pathogens. | EIC Pathfinder | € 3.000.000 | 2025 | Details |
Hacking the ribosome to map virus-host associations
The VirHoX project aims to map virus-host associations using a novel technique, VirHo-seq, to enhance understanding of viral interactions and address challenges posed by emerging pathogens.